| Swati Mayur Daftary, MD | |
|
3103 Breckenridge Ln, Ste 1, Louisville, KY 40220-2798 | |
| (502) 495-5055 | |
| (502) 495-5057 |
| Full Name | Swati Mayur Daftary |
|---|---|
| Gender | Female |
| Speciality | Physical Medicine And Rehabilitation |
| Experience | 39 Years |
| Location | 3103 Breckenridge Ln, Louisville, Kentucky |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1225180896 | NPI | - | NPPES |
| 64306145 | Medicaid | KY |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208100000X | Physical Medicine & Rehabilitation | 30614 (Kentucky) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Jewish Hospital & St Mary's Healthcare | Louisville, KY | Hospital |
| Norton Hospitals, Inc | Louisville, KY | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Rehabilitation Institute Pllc | 3779567706 | 2 |
News Archive
Winner of the Preuss Research Award, Andrew Venteicher, MD, PhD, presented his research, Cellular Architecture of Human IDH1-mutant Gliomas Revealed Using Single-cell RNA Sequencing, during the 2016 American Association of Neurological Surgeons Annual Scientific Meeting.
Bowel Cancer UK welcomes the comments made by Mike Richards at the National Cancer Research Institute highlighting the lack of access to diagnostic tests for bowel cancer. Bowel Cancer UK has been campaigning on this issue for some time. The latest report from the charity, "Diagnosing bowel cancer early: right test, right time," highlights their concerns in more detail.
AVEO Pharmaceuticals, Inc., a biopharmaceutical company focused on discovering, developing and commercializing cancer therapeutics, today announced that it has achieved its enrollment target for TIVO-1, its global Phase 3 clinical trial for its oral, triple VEGF receptor inhibitor, tivozanib, in patients with advanced renal cell carcinoma. In February of this year, AVEO initiated enrollment in TIVO-1, and has successfully reached the target enrollment of 500 patients.
The Center for Strategic & International Studies on Wednesday released two reports on immunizations and global health. "The Future of Global Immunization: Will the Promise Be Fulfilled?," by Stephen Cochi of the CDC, "outlines 10 important issues facing the global vaccine and immunization agenda."
› Verified 2 days ago
| Entity Name | Rehabilitation Institute Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1861580177 PECOS PAC ID: 3779567706 Enrollment ID: O20040616000833 |
News Archive
Winner of the Preuss Research Award, Andrew Venteicher, MD, PhD, presented his research, Cellular Architecture of Human IDH1-mutant Gliomas Revealed Using Single-cell RNA Sequencing, during the 2016 American Association of Neurological Surgeons Annual Scientific Meeting.
Bowel Cancer UK welcomes the comments made by Mike Richards at the National Cancer Research Institute highlighting the lack of access to diagnostic tests for bowel cancer. Bowel Cancer UK has been campaigning on this issue for some time. The latest report from the charity, "Diagnosing bowel cancer early: right test, right time," highlights their concerns in more detail.
AVEO Pharmaceuticals, Inc., a biopharmaceutical company focused on discovering, developing and commercializing cancer therapeutics, today announced that it has achieved its enrollment target for TIVO-1, its global Phase 3 clinical trial for its oral, triple VEGF receptor inhibitor, tivozanib, in patients with advanced renal cell carcinoma. In February of this year, AVEO initiated enrollment in TIVO-1, and has successfully reached the target enrollment of 500 patients.
The Center for Strategic & International Studies on Wednesday released two reports on immunizations and global health. "The Future of Global Immunization: Will the Promise Be Fulfilled?," by Stephen Cochi of the CDC, "outlines 10 important issues facing the global vaccine and immunization agenda."
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Swati Mayur Daftary, MD 3103 Breckenridge Ln, Ste 1, Louisville, KY 40220-2798 Ph: (502) 495-5055 | Swati Mayur Daftary, MD 3103 Breckenridge Ln, Ste 1, Louisville, KY 40220-2798 Ph: (502) 495-5055 |
News Archive
Winner of the Preuss Research Award, Andrew Venteicher, MD, PhD, presented his research, Cellular Architecture of Human IDH1-mutant Gliomas Revealed Using Single-cell RNA Sequencing, during the 2016 American Association of Neurological Surgeons Annual Scientific Meeting.
Bowel Cancer UK welcomes the comments made by Mike Richards at the National Cancer Research Institute highlighting the lack of access to diagnostic tests for bowel cancer. Bowel Cancer UK has been campaigning on this issue for some time. The latest report from the charity, "Diagnosing bowel cancer early: right test, right time," highlights their concerns in more detail.
AVEO Pharmaceuticals, Inc., a biopharmaceutical company focused on discovering, developing and commercializing cancer therapeutics, today announced that it has achieved its enrollment target for TIVO-1, its global Phase 3 clinical trial for its oral, triple VEGF receptor inhibitor, tivozanib, in patients with advanced renal cell carcinoma. In February of this year, AVEO initiated enrollment in TIVO-1, and has successfully reached the target enrollment of 500 patients.
The Center for Strategic & International Studies on Wednesday released two reports on immunizations and global health. "The Future of Global Immunization: Will the Promise Be Fulfilled?," by Stephen Cochi of the CDC, "outlines 10 important issues facing the global vaccine and immunization agenda."
› Verified 2 days ago
Ms. Alisha Davis, Physical Medicine & Rehabilitation Medicare: Not Enrolled in Medicare Practice Location: 6000 Hunting Rd, Louisville, KY 40222 Phone: 812-599-6056 | |
Rizwan N Khan, MD Physical Medicine & Rehabilitation Medicare: Not Enrolled in Medicare Practice Location: 2137 Dixie Hwy, Louisville, KY 40210 Phone: 502-712-1292 Fax: 502-901-9955 | |
Dr. Warren Joseph Bilkey Jr., M.D. Physical Medicine & Rehabilitation Medicare: Not Enrolled in Medicare Practice Location: 1227 Goss Ave, Louisville, KY 40217 Phone: 502-619-1771 Fax: 502-245-1380 | |
James Jason Miller, M.D. Physical Medicine & Rehabilitation Medicare: Accepting Medicare Assignments Practice Location: 300 Shelby Station Dr, Louisville, KY 40245 Phone: 502-254-0009 Fax: 502-753-6460 | |
Karen K. Bloom, M.D. Physical Medicine & Rehabilitation Medicare: Medicare Enrolled Practice Location: 18 River Hill Rd, Louisville, KY 40207 Phone: 502-645-1043 Fax: 815-550-2223 | |
Dr. Camilo Castillo, MD Physical Medicine & Rehabilitation Medicare: Accepting Medicare Assignments Practice Location: 220 Abraham Flexner Way #1200, Louisville, KY 40202 Phone: 502-584-3377 Fax: 502-584-3480 | |
Ellen Margaret Ballard, M.D. Physical Medicine & Rehabilitation Medicare: Accepting Medicare Assignments Practice Location: 1941 Bishop Ln Ste 402, Louisville, KY 40218 Phone: 502-458-2677 Fax: 502-458-2163 |